Cargando…
N-3 Polyunsaturated fatty acid therapy improves endothelial function and affects adiponectin and resistin balance in the first month after myocardial infarction
INTRODUCTION: N-3 Polyunsaturated fatty acids (n-3 PUFA) exert clinical beneficial effects in patients after acute myocardial infarction (AMI). However, their exact mechanisms of action are not well recognized yet. Our aim was to evaluate effects of early introduced n-3 PUFA supplementation on endot...
Autores principales: | Mizia-Stec, Katarzyna, Haberka, Maciej, Mizia, Magdalena, Chmiel, Artur, Gieszczyk, Klaudia, Lasota, Bartosz, Janowska, Joanna, Zahorska-Markiewicz, Barbara, Gąsior, Zbigniew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258804/ https://www.ncbi.nlm.nih.gov/pubmed/22291823 http://dx.doi.org/10.5114/aoms.2011.25553 |
Ejemplares similares
-
Serum ADMA concentration – an independent factor determining FMD impairment in cardiac syndrome X
por: Haberka, Maciej, et al.
Publicado: (2009) -
Severe degenerative aortic stenosis with preserved ejection fraction does not change adipokines serum levels
por: Mizia-Stec, Katarzyna, et al.
Publicado: (2019) -
The use of iloprost in the treatment of ‘out of proportion’ pulmonary hypertension in chronic obstructive pulmonary disease
por: Lasota, Bartosz, et al.
Publicado: (2013) -
CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
por: Gieszczyk-Strózik, Klaudia, et al.
Publicado: (2021) -
Angiopoietin-2 as a biomarker of non-ST-segment elevation myocardial infarction in patients with or without type 2 diabetes
por: Skowerski, Tomasz, et al.
Publicado: (2019)